Uncategorized
CGT Global Welcomes Dr. Jerome Ritz to Its Board of Advisors, Enriching Knowledge of Cellular Therapies and Hematology
By:CGT GlobalviaBusiness Wire August 14, 2025 at 09:00 AM EDT CGT Global, a biotechnology leader accelerating access to life-changing cell and gene therapies, today announced the appointment of Jerome Ritz, MD, to its Board of Advisors. Dr. Ritz brings a distinguished career in hematology, oncology, cell manufacturing, and the advancement of cell and gene therapies.…
For More InformationCGT Global Appoints Dr. Andrew Branagan to Board of Advisors, Expanding Cell and Gene Therapy Expertise
CGT Global, a leading biotechnology company driving the development and delivery of innovative cell and gene therapies, today announced the appointment of Andrew Robert Branagan, MD, PhD, to its Board of Advisors. Dr. Branagan brings extensive expertise in hematologic malignancies, immunology, and the development of novel therapeutic strategies, including cellular therapies. This press release features…
For More InformationBehind the Scenes at CGT Global’s Laboratory: Life in the Lab with Bryan
By Joanna Wirkus, PhD CD34+ Cell Isolation Process Previously in our Meet the Scientific Team blog, we gained insight into the background of CGT Global’s Laboratory Operations Manager in Folsom, California — Bryan — and his inspiration for his work. Today, we go behind the scenes, or behind the bench, to see what a day…
For More InformationMeet CGT Global’s Scientific Team: Bryan Pulling – Laboratory Operations Manager
Written by Joanna Wirkus, PhD Every day at CGT Global, our experienced team collaborates to deliver high quality cells to scientists around the world. Success starts with the strength of our team and the dedication of the people who power it. In this edition of Meet the Scientific Team, we’re proud to spotlight Bryan Pulling…
For More InformationCord Blood CD34+ Cells: High Viability for Humanized Mouse Models
By: Joanna Wirkus The Rise of Cord Blood CD34+ Cells in Humanized Mouse Models and Cell Therapy Innovation Scientists in the late 1980’s discovered that umbilical cord blood derived stem cells had high proliferative potential and tolerated cryopreservation and thawing (Broxmeyer, 1989). Building on this research, the first report of cord blood derived CD34+ human…
For More InformationCellsExpress: Affordable, Bulk Isolated Bone Marrow-Derived Stem Cells That Accelerate Your Cell and Gene Therapy Research
By Joanna Wirkus Bulk Bone Marrow Stem Cells for Research | CGT Global The race to develop life-saving cell and gene therapies is intensifying. Amid shifting political pressures, uncertain funding landscapes, and rising inflation, scientists are being asked to do more with less. Time, money, and labor must be optimized at every step—and that starts…
For More InformationGene Therapy Research: Past, Present, Future
Gene Therapy Research: Past, Present, Future By: Joanna Wirkus Gene Therapy: Where We’ve Been: The Human Genome Project concluded in 2003 after 13 years of effort aimed at mapping the entire Human Genome and improving DNA sequencing technology at large. This milestone set the foundation for a better understanding of the drivers of disease…
For More InformationCell Therapy Research: Past, Present, and Future
Cell Therapy Research: Past, Present, and Future By Joanna Wirkus The drive to understand the origins of disease has led us to investigate the basic unit of life, the cell. Historically, it was thought that demons, spells, or ‘bad air’ caused illness. Over three and a half centuries, science has advanced to better understand how…
For More InformationCGT Global Attends Advanced Therapies USA 2024 to Support Cell and Gene Therapy Innovation
CGT Global’s Cate Spears and Eliona Kola attend Advanced Therapies USA 2024, engaging with industry leaders to advance cell and gene therapy innovation. Attending Advanced Therapies USA is a valuable opportunity to engage with global leaders and drive innovation in cell and gene therapy.”— Cate Spears, CEO of CGT Global, FOLSOM, CA, UNITED STATES, November…
For More InformationWebinar: Access to Cell and Gene Therapies
Addressing Disparities in Access to Cell and Gene Therapies We are thrilled to share the fantastic outcome of our recent webinar, ” Addressing Disparities in Access to Cell and Gene Therapies.” The engagement and insightful discussions during the session were truly remarkable, and we want to extend our heartfelt gratitude to all who participated. Missed…
For More Information